Your browser doesn't support javascript.
loading
Nimbolide: promising agent for prevention and treatment of chronic diseases (recent update).
Rajendran, Peramaiyan; Renu, Kaviyarasi; Abdallah, Basem M; Ali, Enas M; Veeraraghavan, Vishnu Priya; Sivalingam, Kalaiselvi; Rustagi, Yashika; Abdelsalam, Salaheldin Abdelraouf; Ibrahim, Rashid Ismael Hag; Al-Ramadan, Saeed Yaseen.
Afiliação
  • Rajendran P; Department of Biological Sciences, College of Science, King Faisal University, Al Ahsa, Saudi Arabia.
  • Renu K; Centre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College & Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India.
  • Abdallah BM; Centre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College & Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India.
  • Ali EM; Department of Biological Sciences, College of Science, King Faisal University, Al Ahsa, Saudi Arabia.
  • Veeraraghavan VP; Department of Biological Sciences, College of Science, King Faisal University, Al Ahsa, Saudi Arabia.
  • Sivalingam K; Department of Botany and Microbiology, Faculty of Science, Cairo University, Cairo, Egypt.
  • Rustagi Y; Centre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College & Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India.
  • Abdelsalam SA; Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, MA, USA.
  • Ibrahim RIH; Centre for Cancer Genomics, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Al-Ramadan SY; Department of Biological Sciences, College of Science, King Faisal University, Al Ahsa, Saudi Arabia.
Food Nutr Res ; 682024.
Article em En | MEDLINE | ID: mdl-38571915
ABSTRACT

Background:

Nimbolide, a bioactive compound derived from the neem tree, has garnered attention as a potential breakthrough in the prevention and treatment of chronic diseases. Recent updates in research highlight its multifaceted pharmacological properties, demonstrating anti-inflammatory, antioxidant, and anticancer effects. With a rich history in traditional medicine, nimbolide efficacy in addressing the molecular complexities of conditions such as cardiovascular diseases, diabetes, and cancer positions it as a promising candidate for further exploration. As studies progress, the recent update underscores the growing optimism surrounding nimbolide as a valuable tool in the ongoing pursuit of innovative therapeutic strategies for chronic diseases.

Methods:

The comprehensive search of the literature was done until September 2020 on the MEDLINE, Embase, Scopus and Web of Knowledge databases.

Results:

Most studies have shown the Nimbolide is one of the most potent limonoids derived from the flowers and leaves of neem (Azadirachta indica), which is widely used to treat a variety of human diseases. In chronic diseases, nimbolide reported to modulate the key signaling pathways, such as Mitogen-activated protein kinases (MAPKs), Wingless-related integration site-ß (Wnt-ß)/catenin, NF-κB, PI3K/AKT, and signaling molecules, such as transforming growth factor (TGF-ß), Matrix metalloproteinases (MMPs), Vascular Endothelial Growth Factor (VEGF), inflammatory cytokines, and epithelial-mesenchymal transition (EMT) proteins. Nimbolide has anti-inflammatory, anti-microbial, and anti-cancer properties, which make it an intriguing compound for research. Nimbolide demonstrated therapeutic potential for osteoarthritis, rheumatoid arthritis, cardiovascular, inflammation and cancer.

Conclusion:

The current review mainly focused on understanding the molecular mechanisms underlying the therapecutic effects of nimbolide in chronic diseases.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Food & nutrition research (Online) / Food Nutr Res Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Arábia Saudita

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Food & nutrition research (Online) / Food Nutr Res Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Arábia Saudita